These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 32064766)

  • 1. Redefining and revisiting cost estimates of routine ART care in Zambia: an analysis of ten clinics.
    Tucker A; Tembo T; Tampi RP; Mutale J; Mukumba-Mwenechanya M; Sharma A; Dowdy DW; Moore CB; Geng E; Holmes CB; Sikazwe I; Sohn H
    J Int AIDS Soc; 2020 Feb; 23(2):e25431. PubMed ID: 32064766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Annual cost of antiretroviral therapy among three service delivery models in Uganda.
    Vu L; Waliggo S; Zieman B; Jani N; Buzaalirwa L; Okoboi S; Okal J; Borse NN; Kalibala S
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20840. PubMed ID: 27443270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Retention in care, resource utilization, and costs for adults receiving antiretroviral therapy in Zambia: a retrospective cohort study.
    Scott CA; Iyer HS; McCoy K; Moyo C; Long L; Larson BA; Rosen S
    BMC Public Health; 2014 Mar; 14():296. PubMed ID: 24684772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The costs of providing antiretroviral therapy services to HIV-infected individuals presenting with advanced HIV disease at public health centres in Dar es Salaam, Tanzania: Findings from a randomised trial evaluating different health care strategies.
    Kimaro GD; Mfinanga S; Simms V; Kivuyo S; Bottomley C; Hawkins N; Harrison TS; Jaffar S; Guinness L;
    PLoS One; 2017; 12(2):e0171917. PubMed ID: 28234969
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Taking ART to scale: determinants of the cost and cost-effectiveness of antiretroviral therapy in 45 clinical sites in Zambia.
    Marseille E; Giganti MJ; Mwango A; Chisembele-Taylor A; Mulenga L; Over M; Kahn JG; Stringer JS
    PLoS One; 2012; 7(12):e51993. PubMed ID: 23284843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-country analysis of treatment costs for HIV/AIDS (MATCH): facility-level ART unit cost analysis in Ethiopia, Malawi, Rwanda, South Africa and Zambia.
    Tagar E; Sundaram M; Condliffe K; Matatiyo B; Chimbwandira F; Chilima B; Mwanamanga R; Moyo C; Chitah BM; Nyemazi JP; Assefa Y; Pillay Y; Mayer S; Shear L; Dain M; Hurley R; Kumar R; McCarthy T; Batra P; Gwinnell D; Diamond S; Over M
    PLoS One; 2014; 9(11):e108304. PubMed ID: 25389777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incremental treatment costs for HIV-infected women initiating antiretroviral therapy during pregnancy: A 24-month micro-costing cohort study for a maternal and child health clinic in Kenya.
    Larson BA; Bii M; Halim N; Rohr JK; Sugut W; Sawe F
    PLoS One; 2018; 13(8):e0200199. PubMed ID: 30096177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina Faso.
    Cianci F; Sweeney S; Konate I; Nagot N; Low A; Mayaud P; Vickerman P
    PLoS One; 2014; 9(6):e100107. PubMed ID: 24950185
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Varying intervals of antiretroviral medication dispensing to improve outcomes for HIV patients (The INTERVAL Study): study protocol for a randomized controlled trial.
    Hoffman R; Bardon A; Rosen S; Fox M; Kalua T; Xulu T; Taylor A; Sanne I
    Trials; 2017 Oct; 18(1):476. PubMed ID: 29029644
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Retention in care and outpatient costs for children receiving antiretroviral therapy in Zambia: a retrospective cohort analysis.
    Scott CA; Iyer H; Bwalya DL; McCoy K; Meyer-Rath G; Moyo C; Bolton-Moore C; Larson B; Rosen S
    PLoS One; 2013; 8(6):e67910. PubMed ID: 23840788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strengthening health systems at facility-level: feasibility of integrating antiretroviral therapy into primary health care services in lusaka, zambia.
    Topp SM; Chipukuma JM; Giganti M; Mwango LK; Chiko LM; Tambatamba-Chapula B; Wamulume CS; Reid S
    PLoS One; 2010 Jul; 5(7):e11522. PubMed ID: 20644629
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cost of providing comprehensive HIV treatment in PEPFAR-supported programs.
    Menzies NA; Berruti AA; Berzon R; Filler S; Ferris R; Ellerbrock TV; Blandford JM
    AIDS; 2011 Sep; 25(14):1753-60. PubMed ID: 21412127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Costs of implementing universal test and treat in three correctional facilities in South Africa and Zambia.
    Mukora R; Smith HJ; Herce ME; Chimoyi L; Hausler H; Fielding KL; Charalambous S; Hoffmann CJ
    PLoS One; 2022; 17(8):e0272595. PubMed ID: 36006967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Costs and Cost Drivers of Providing Option B+ Services to Mother-Baby Pairs for PMTCT of HIV in Health Centre IV Facilities in Jinja District, Uganda.
    Mukose AD; Kebede S; Muhumuza C; Makumbi F; Komakech H; Bayiga E; Busobozi D; Musinguzi J; Kuznik A; Stegman P; Forsythe S; Kagaayi J
    Biomed Res Int; 2020; 2020():2875864. PubMed ID: 32550228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Costing analysis of national HIV treatment and care program in Vietnam.
    Duong AT; Kato M; Bales S; Do NT; Minh Nguyen TT; Thanh Cao TT; Nguyen LT
    J Acquir Immune Defic Syndr; 2014 Jan; 65(1):e1-7. PubMed ID: 23846564
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness analysis of the national decentralization policy of antiretroviral treatment programme in Zambia.
    Miyano S; Syakantu G; Komada K; Endo H; Sugishita T
    Cost Eff Resour Alloc; 2017; 15():4. PubMed ID: 28413361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients.
    Nichols BE; Cele R; Lekodeba N; Tukei B; Ngorima-Mabhena N; Tiam A; Maotoe T; Sejana MV; Faturiyele IO; Chasela C; Rosen S; Fatti G
    J Int AIDS Soc; 2021 Apr; 24(4):e25692. PubMed ID: 33838012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estimated Costs for Delivery of HIV Antiretroviral Therapy to Individuals with CD4+ T-Cell Counts >350 cells/uL in Rural Uganda.
    Jain V; Chang W; Byonanebye DM; Owaraganise A; Twinomuhwezi E; Amanyire G; Black D; Marseille E; Kamya MR; Havlir DV; Kahn JG
    PLoS One; 2015; 10(12):e0143433. PubMed ID: 26632823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uptake, outcomes, and costs of antenatal, well-baby, and prevention of mother-to-child transmission of HIV services under routine care conditions in Zambia.
    Scott CA; Iyer HS; Lembela Bwalya D; Bweupe M; Rosen SB; Scott N; Larson BA
    PLoS One; 2013; 8(8):e72444. PubMed ID: 24015245
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health outcomes and cost impact of the new WHO 2013 guidelines on prevention of mother-to-child transmission of HIV in Zambia.
    Ishikawa N; Shimbo T; Miyano S; Sikazwe I; Mwango A; Ghidinelli MN; Syakantu G
    PLoS One; 2014; 9(3):e90991. PubMed ID: 24604067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.